A Study of MK-6837 as a Monotherapy and Combination Therapy in Participants With Advanced/Metastatic Solid Tumors (MK-6837-001)
Clinical trial NCT06460961 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06460961
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-14
- Primary completion
- 2027-07-13
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.